ACSG - ETF AI Analysis
Top Page
American Century Small Cap Growth Insights ETF (ACSG)
Rating:62Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and over the past few months, showing solid recent momentum.
Top Holdings Showing Solid Growth
Many of the largest positions, including companies in health care and technology, have posted strong year-to-date gains that support the fund’s results.
Broad Sector Diversification
Holdings spread across many sectors, with meaningful weights in health care, technology, and industrials, help reduce the impact of weakness in any single industry.
Negative Factors
High U.S. Concentration
The fund is heavily focused on U.S. stocks, offering very limited exposure to other countries and less geographic diversification.
Moderately High Expense Ratio
The ETF’s expense ratio is on the higher side for a passive-style product, which can eat into long-term returns compared with lower-cost options.
Sector Tilt Toward Health Care and Technology
A large share of assets in health care and technology means the fund could be more sensitive to downturns or volatility in these growth-oriented sectors.
ACSG vs. SPDR S&P 500 ETF (SPY)
AUM51.20M
RegionNorth America
Expense Ratio0.49%
Beta1.24
IssuerAmerican Century
Inception DateOct 14, 2025
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume3,622
30 Day Avg. Volume10,813
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
64.16Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering308
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ACSG Summary
The American Century Small Cap Growth Insights ETF (ACSG) is an actively managed fund that focuses on smaller U.S. companies with the potential for fast growth, rather than tracking a set index. It invests across many areas of the economy, with a lot in health care and technology, and holds names like 10x Genomics and Qualys. Someone might consider ACSG to seek long-term growth and to diversify beyond large, well-known stocks. A key risk is that small-company shares can be more volatile, so the ETF’s value can rise and fall more sharply than the overall market.
How much will it cost me?The American Century Small Cap Growth Insights ETF (ACSG) has an expense ratio of 0.49%, meaning you’ll pay $4.90 per year for every $1,000 invested. This cost is higher than average because the fund is actively managed, which involves more research and decision-making compared to passively managed ETFs that track an index.
What would affect this ETF?The ACSG ETF, focused on U.S. small-cap growth companies, could benefit from innovation and expansion in sectors like technology and healthcare, which make up a significant portion of its holdings. However, it may face challenges during economic downturns, as small-cap stocks are often more volatile and sensitive to interest rate hikes or reduced consumer spending. Regulatory changes or sector-specific disruptions could also impact its performance negatively.
ACSG Top 10 Holdings
ACSG is leaning hard into U.S. small-cap health care and tech, with names like 10x Genomics and Krystal Biotech doing much of the heavy lifting as their shares keep rising on strong growth stories. On the industrial and tech side, Plexus and Hexcel have been more mixed lately, with recent softness acting like a bit of a headwind even as their longer-term trends stay constructive. Agilysys and Expro add a tech-and-energy twist, but the fund’s story is still a U.S.-centric bet on nimble, fast-growing innovators rather than global giants.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| 10x Genomics | 1.08% | $549.83K | $11.17B | 680.42% | 60 Neutral | |
| Ceco Environmental | 1.01% | $513.74K | $4.30B | 43.72% | 72 Outperform | |
| Krystal Biotech | 0.98% | $500.88K | $10.24B | 90.71% | 80 Outperform | |
| Sensient Technologies | 0.89% | $451.59K | $5.50B | 38.58% | 63 Neutral | |
| Plexus | 0.88% | $451.02K | $7.01B | 84.94% | 75 Outperform | |
| Twist Bioscience | 0.80% | $409.83K | $12.04B | 565.18% | 43 Neutral | |
| Hexcel | 0.80% | $409.82K | $6.49B | 36.55% | 73 Outperform | |
| Expro Group Holdings | 0.77% | $393.34K | $1.83B | 32.90% | 77 Outperform | |
| Riot Platforms | 0.77% | $391.53K | $8.63B | 9.30% | 68 Neutral | |
| Radnet | 0.77% | $390.42K | $5.57B | -3.87% | 63 Neutral |
ACSG Technical Analysis
Negative
―
Price Trends
48.41
Negative
48.02
Negative
45.06
Positive
Market Momentum
-0.70
Positive
34.71
Neutral
12.38
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ACSG, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 47.14, equal to the 50-day MA of 48.41, and equal to the 200-day MA of 45.06, indicating a neutral trend. The MACD of -0.70 indicates Positive momentum. The RSI at 34.71 is Neutral, neither overbought nor oversold. The STOCH value of 12.38 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ACSG.
ACSG Peer Comparison
Comparison Results
Performance Comparison
ACSG
American Century Small Cap Growth Insights ETF
45.99
5.94
14.83%
TMFS
Motley Fool Small-Cap Growth ETF
―
―
―
MMSC
First Trust Multi-Manager Small Cap Opportunities ETF
―
―
―
SGRW
Harbor Active Small Cap Growth ETF
―
―
―
SAWS
AAM Sawgrass US Small Cap Quality Growth ETF
―
―
―
FSEG
Fidelity Enhanced Small Cap Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents